Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 16/20 | 0.84 |
| ▸ | SSTR5 | P35346 | 15/20 | 0.84 |
| ▸ | SSTR4 | P31391 | 9/20 | 0.84 |
| ▸ | SSTR3 | P32745 | 9/20 | 0.84 |
| ▸ | SSTR1 | P30872 | 3/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21099762 | 0.96 | SSTR2 (0.78) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Vapreotide SCHEMBL29405608 | 0.95 | SSTR2 (0.81) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Vapreotide SCHEMBL31632623 | 0.95 | SSTR2 (0.81) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Vapreotide SCHEMBL4826 | 0.95 | SSTR2 (0.81) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Vapreotide SCHEMBL6369050 | 0.95 | SSTR2 (0.81) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Vapreotide SCHEMBL30163296 | 0.95 | SSTR2 (0.81) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL18712687 | 0.95 | SSTR2 (0.81) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Vapreotide SCHEMBL4827 | 0.95 | SSTR2 (0.81) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL30044563 | 0.94 | SSTR2 (0.82) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| Vapreotide SCHEMBL294911 | 0.94 | SSTR2 (0.80) | SSTR2SSTR5SSTR4SSTR3SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4251213-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM Solucin GmbH (DE) | 2023-10-04 | — | — | EP | disclosed |
| EP-4065176-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotope Technologies Munich SE (DE) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022112323-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM SOLUCIN GMBH (DE) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022111800-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | ITM SOLUCIN GMBH (DE) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022096103-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotopen Technologien München AG (DE) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022096673-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotopen Technologien München AG (DE) | 2022-05-12 | — | — | WO | disclosed |
| EP-3965751-A1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | ITM Isotope Technologies Munich SE (DE) | 2022-03-16 | — | — | EP | disclosed |